Mesothelioma Cancer Resources Blog

Researchers from the University of Tsukuba in Japan reported in the October issue of the International Journal of Radiation Oncology•Biology•Physics that proton beam therapy was effective and well tolerated in inoperable patients with Stage I non-small cell lung cancer (NSCLC).  A Swedish group of oncologists also confirm the effectiveness of the therapy saying proton therapy …

by Nancy Meredith University of Texas M.D. Anderson Cancer Center, with over 30 specialists on staff to support the treatment of mesothelioma patients and one of the premier treatment centers for mesothelioma, reports that there is a shortage of radiation oncologists in the United States and it could impact the treatment cancer patients receive in …

Since awarding its first cancer research grant in 1998 the Lance Armstrong Foundation, now known as LIVESTRONG, had awarded more than $18.7 million in research grants by 2007, and that figure continues to grow annually.  This week LIVESTRONG will be awarding another $650,000 through their Community Impact Program.  Among centers up for the various awards …

Researchers at the University of Chicago shared their lab this summer with students from Chicago-area high schools in an effort to introduce the students to cancer research and to interest them in the various careers available in the medical field related to cancer.  The students worked on activities involving lung cancer, breast cancer, acute myeloid …

Athletic events are becoming more popular as opportunities for foundations and organizations to appeal to the public to help raise money to fund critical research that is still needed to find a cure for many diseases, such as mesothelioma and other types of lung cancer.  Team Labrecque: Uniting Against Lung Cancer has joined the effort …

Many clinical trials assessing the efficacy of treatments for patients with malignant mesothelioma in the last 20 years have made no distinction between peritoneal mesothelioma and the more common pleural mesothelioma.  This has led Richard Alexander, Jr., M.D., of the University Of Maryland School Of Medicine, to state that it has become increasingly clear that …

According to a study published in August in the British Journal of Cancer, researchers have found that malignant pleural mesothelioma patients contained a higher concentration of intelectin-1 than those of lung cancer patients.  These results suggest that when intelectin-1 is present in high concentrations in pleural effusions it may be useful as a marker to …

Mesothelioma is a rare, aggressive cancer caused by asbestos exposure that affects close to 3,000 Americans each year.  Although ongoing research is being conducted to find a cure for mesothelioma, it is still considered to be incurable.  The average survival time is less than 2 years, and support from family and friends is crucial to …

Mesothelioma is a serious cancer, most commonly found in the outer lining of the lungs called the mesothelium, that occurs in individuals exposed to airborne asbestos fibers. Mesothelioma is highly aggressive and is resistant to many standard cancer treatments making it a difficult disease to treat effectively.  The prognosis for mesothelioma patients is usually grim: …

Professor George Kannourakis of Ballarat Cancer Research Center in Australia hopes to launch a series of clinical trials focused on mesothelioma and lung cancer patients.   The clinical trials will be used to identify a method that will administer chemotherapy drugs directly to the tumor, destroying only the cancerous cells while preserving healthy cells.  The pioneer …